Search

7 results for “Retatrutide”

Retatrutide
Clinical trial data
Metabolic

Retatrutide

LY3437943 · Acylated tri-agonist peptide (GLP-1 / GIP / glucagon receptor)

Half-life~6.0 days
RouteSubQ injection
Sign in for detailsView
Semaglutide
Approved therapeutic
Metabolic

Semaglutide

Half-life~7 days
RouteSubQ injection
Sign in for detailsView
Tirzepatide
Approved therapeutic
Metabolic

Tirzepatide

Half-life~5.0 days
RouteSubQ injection
Sign in for detailsView
SS-31 (Elamipretide)
Clinical trial data
Longevity

SS-31 (Elamipretide)

Half-life~4.5 hours
RouteSubQ injection
Sign in for detailsView
MOTS-C
Early human data
LongevityMetabolic

MOTS-C

Half-life~3 hours
RouteSubQ injection
Sign in for detailsView
KLOW Blend (BPC 10mg + TB 10mg + GHK-Cu 50mg + KPV 10mg)
Preclinical only
Ben Greenfield
BlendsHealingSkin

KLOW BlendBPC 10mg + TB 10mg + GHK-Cu 50mg + KPV 10mg

Half-life~5 hours
RouteSubQ injection
Sign in for detailsView
Tesamorelin
Approved therapeutic
GrowthMetabolic

Tesamorelin

Half-life~26 minutes
RouteSubQ injection
Sign in for detailsView